Our entire activity since inception up to June 30, 2021 was in preparation for our formation and the Initial Public Offering. We will not be generating any operating revenues until the closing and completion of our initial Business Combination.
For the three months ended June 30, 2021, we had a net loss of approximately $939,000, which consisted of a loss from operations of approximately $363,000 comprised of approximately $283,000 general and administrative expenses, approximately $30,000 in general and administrative expenses to a related party and approximately $49,000 of franchise tax expense, and a
non-operating
loss resulting from a change in fair value of derivative warrant liabilities of $582,000, partially offset by approximately $6,000 of income from investments held in the Trust Account.
For the period from January 5, 2021 (inception) through June 30, 2021, we had a net loss of approximately $463,000, which consisted of a loss from operations of approximately $490,000 comprised of approximately $353,000 general and administrative expenses, approximately $39,000 in general and administrative expenses to a related party and approximately $98,000 of franchise tax expense, and a
non-operating
loss of approximately $424,000 for offering costs associated with derivative warrant liabilities, partially offset by
non-operating
income resulting from a change in fair value of derivative warrant liabilities of approximately $444,000 and approximately $7,000 of income from investments held in the Trust Account.
Administrative Services Agreement
Commencing on the date that our securities were first listed on Nasdaq through the earlier of consummation of the initial Business Combination and our liquidation, we agreed to pay an affiliate of the Sponsor a total of $10,000 per month for office space, administrative and support services.
The Sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any
expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. Our audit committee will review on a quarterly basis all payments that were made to the Sponsor, our directors, our officers or any of their affiliates.
The Company incurred approximately $30,000 and $39,000 in general and administrative expenses in the accompanying unaudited statements of operations for the three months ended June 30,2021 and for the period from January 5, 2021 (inception) through June 30, 2021, respectively.
We granted the underwriters a
45-day
option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less underwriting discounts and commissions. The underwriters exercised the over-allotment option in full and on March 16, 2021, purchasing an additional 4,500,000 Units.
The underwriters are entitled to an underwriting discount of $0.20 per Unit, or $6.9 million in the aggregate, paid upon the closing of the Initial Public Offering and sale of Over-Allotment Units. An additional fee of $0.35 per Unit, or approximately $12.1 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Policies
Derivative warrant liabilities
We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be accounted for as liabilities or as equity, is
re-assessed
at the end of each reporting period.